SH3GL1
Basic information
Region (hg38): 19:4360370-4400547
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SH3GL1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 23 | 24 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 6 | |||||
Total | 0 | 0 | 23 | 2 | 9 |
Variants in SH3GL1
This is a list of pathogenic ClinVar variants found in the SH3GL1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-4361606-C-T | not specified | Likely benign (Sep 11, 2024) | ||
19-4361642-G-A | Benign (Oct 19, 2017) | |||
19-4361706-G-A | not specified | Uncertain significance (Jun 03, 2024) | ||
19-4361713-C-T | not specified | Likely benign (Nov 21, 2022) | ||
19-4361740-C-T | not specified | Uncertain significance (Jun 07, 2023) | ||
19-4361755-C-G | not specified | Uncertain significance (Dec 13, 2021) | ||
19-4361994-GTT-G | Benign (Nov 12, 2018) | |||
19-4362338-G-A | not specified | Uncertain significance (May 27, 2022) | ||
19-4362349-C-T | not specified | Uncertain significance (May 26, 2022) | ||
19-4362362-C-T | not specified | Uncertain significance (Feb 28, 2023) | ||
19-4362370-C-G | not specified | Uncertain significance (Aug 08, 2022) | ||
19-4362370-C-T | not specified | Uncertain significance (May 31, 2023) | ||
19-4362620-T-C | not specified | Uncertain significance (Jun 16, 2023) | ||
19-4362627-C-T | not specified | Uncertain significance (Mar 01, 2023) | ||
19-4362655-C-G | not specified | Uncertain significance (Sep 20, 2023) | ||
19-4362687-G-A | not specified | Uncertain significance (Dec 17, 2023) | ||
19-4362694-G-C | Acute myeloid leukemia | Benign (Jul 15, 2021) | ||
19-4362707-C-T | not specified | Uncertain significance (Apr 12, 2024) | ||
19-4362735-T-A | not specified | Uncertain significance (Jun 24, 2022) | ||
19-4363173-G-T | Benign (Nov 12, 2018) | |||
19-4363292-C-T | Benign (Jun 19, 2021) | |||
19-4363374-G-A | not specified | Uncertain significance (Mar 08, 2024) | ||
19-4363410-C-T | not specified | Uncertain significance (Apr 13, 2022) | ||
19-4363416-G-C | not specified | Uncertain significance (Jan 23, 2024) | ||
19-4363418-C-T | not specified | Uncertain significance (Jun 28, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SH3GL1 | protein_coding | protein_coding | ENST00000269886 | 10 | 40178 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0117 | 0.987 | 125712 | 0 | 17 | 125729 | 0.0000676 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.918 | 195 | 235 | 0.831 | 0.0000170 | 2391 |
Missense in Polyphen | 37 | 63.344 | 0.58411 | 681 | ||
Synonymous | -3.26 | 155 | 111 | 1.39 | 0.00000895 | 701 |
Loss of Function | 2.77 | 7 | 20.6 | 0.340 | 0.00000111 | 231 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000285 | 0.000277 |
European (Non-Finnish) | 0.0000629 | 0.0000615 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000666 | 0.0000653 |
Other | 0.000168 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Implicated in endocytosis. May recruit other proteins to membranes with high curvature (By similarity). {ECO:0000250}.;
- Disease
- DISEASE: Note=In some cases of acute leukemia, a translocation results in the formation of a KMT2A/MLL1-EEN fusion gene. {ECO:0000269|PubMed:9122235}.;
- Pathway
- Endocytosis - Homo sapiens (human);Disease;Signal Transduction;Vesicle-mediated transport;Membrane Trafficking;Infectious disease;EGFR downregulation;Signaling by EGFR;Clathrin-mediated endocytosis;Cargo recognition for clathrin-mediated endocytosis;Negative regulation of MET activity;Signaling by MET;Signaling by Receptor Tyrosine Kinases;Signaling events mediated by focal adhesion kinase;InlB-mediated entry of Listeria monocytogenes into host cell;Listeria monocytogenes entry into host cells
(Consensus)
Intolerance Scores
- loftool
- 0.292
- rvis_EVS
- -1.02
- rvis_percentile_EVS
- 8
Haploinsufficiency Scores
- pHI
- 0.0687
- hipred
- Y
- hipred_score
- 0.756
- ghis
- 0.588
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.907
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sh3gl1
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); growth/size/body region phenotype;
Gene ontology
- Biological process
- signal transduction;central nervous system development;synaptic vesicle uncoating;modulation of excitatory postsynaptic potential;positive regulation of synaptic vesicle endocytosis
- Cellular component
- podosome;cytoplasm;cytosol;cell junction;early endosome membrane;cell projection;Schaffer collateral - CA1 synapse;hippocampal mossy fiber to CA3 synapse;presynapse;glutamatergic synapse;postsynaptic density, intracellular component
- Molecular function
- protein binding;protein C-terminus binding;lipid binding;SH3 domain binding;phosphatase binding;beta-1 adrenergic receptor binding;identical protein binding;ion channel binding;cadherin binding;GTPase binding